Zhejiang Wecome Pharmaceutical Company Limited reported earnings results for the first quarter ended March 31, 2022. For the first quarter, the company reported sales was CNY 183.78 million compared to CNY 132.26 million a year ago. Revenue was CNY 183.78 million compared to CNY 132.26 million a year ago. Net income was CNY 22.92 million compared to CNY 20.27 million a year ago. Basic earnings per share from continuing operations was CNY 0.1556 compared to CNY 0.1389 a year ago. Diluted earnings per share from continuing operations was CNY 0.1556 compared to CNY 0.1389 a year ago.